Markus Bosmann, MD
Associate Professor, Medicine
Biography
Dr. Bosmann is an assistant professor at the Boston University School of Medicine. His research interests include pulmonary disorders and their connections to innate immunity, host-pathogen interactions, and inflammation.
Other Positions
- Associate Professor, Pathology & Laboratory Medicine, Boston University School of Medicine
- Member, Pulmonary Center, Boston University
- Member, Evans Center for Interdisciplinary Biomedical Research, Boston University
- Member, Genome Science Institute, Boston University
- Graduate Faculty (Primary Mentor of Grad Students), Boston University School of Medicine, Graduate Medical Sciences
Education
- Goethe University Frankfurt, MD
Publications
- Published on 3/30/2022
Sharma A, Noon JB, Kontodimas K, Garo LP, Platten J, Quinton LJ, Urban JF, Reinhardt C, Bosmann M. IL-27 Enhances ?d T Cell-Mediated Innate Resistance to Primary Hookworm Infection in the Lungs. J Immunol. 2022 Apr 15; 208(8):2008-2018. PMID: 35354611.
Read at: PubMed - Published on 3/5/2022
Carossino M, Kenney D, O'Connell AK, Montanaro P, Tseng AE, Gertje HP, Grosz KA, Ericsson M, Huber BR, Kurnick SA, Subramaniam S, Kirkland TA, Walker JR, Francis KP, Klose AD, Paragas N, Bosmann M, Saeed M, Balasuriya UBR, Douam F, Crossland NA. Fatal Neurodissemination and SARS-CoV-2 Tropism in K18-hACE2 Mice Is Only Partially Dependent on hACE2 Expression. Viruses. 2022 03 05; 14(3). PMID: 35336942.
Read at: PubMed - Published on 2/7/2022
Sanders NL, Martin IMC, Sharma A, Jones MR, Quinton LJ, Bosmann M, Mizgerd JP. Neutrophil Extracellular Traps as an Exacerbating Factor in Bacterial Pneumonia. Infect Immun. 2022 03 17; 90(3):e0049121. PMID: 35130455.
Read at: PubMed - Published on 9/28/2021
Sharma A, Kontodimas K, Bosmann M. The MAVS Immune Recognition Pathway in Viral Infection and Sepsis. Antioxid Redox Signal. 2021 12; 35(16):1376-1392. PMID: 34348482.
Read at: PubMed - Published on 7/23/2021
Helmstädter J, Keppeler K, Aust F, Küster L, Frenis K, Filippou K, Vujacic-Mirski K, Tsohataridis S, Kalinovic S, Kröller-Schön S, Oelze M, Bosmann M, Münzel T, Daiber A, Steven S. GLP-1 Analog Liraglutide Improves Vascular Function in Polymicrobial Sepsis by Reduction of Oxidative Stress and Inflammation. Antioxidants (Basel). 2021 Jul 23; 10(8). PMID: 34439423.
Read at: PubMed - Published on 7/7/2021
Subramaniam S, Ruf W, Bosmann M. Advocacy of targeting protease-activated receptors in severe coronavirus disease 2019. Br J Pharmacol. 2022 May; 179(10):2086-2099. PMID: 34235728.
Read at: PubMed - Published on 6/4/2021
Sharma A, Kontodimas K, Bosmann M. Nanomedicine: A Diagnostic and Therapeutic Approach to COVID-19. Front Med (Lausanne). 2021; 8:648005. PMID: 34150793.
Read at: PubMed - Published on 5/25/2021
Bosmann M. Complement control for COVID-19. Sci Immunol. 2021 05 25; 6(59). PMID: 34035117.
Read at: PubMed - Published on 3/11/2021
Leister H, Luu M, Staudenraus D, Lopez Krol A, Mollenkopf HJ, Sharma A, Schmerer N, Schulte LN, Bertrams W, Schmeck B, Bosmann M, Steinhoff U, Visekruna A. Pro- and Antitumorigenic Capacity of Immunoproteasomes in Shaping the Tumor Microenvironment. Cancer Immunol Res. 2021 06; 9(6):682-692. PMID: 33707310.
Read at: PubMed - Published on 1/15/2021
Carossino M, Montanaro P, O'Connell A, Kenney D, Gertje H, Grosz KA, Kurnick SA, Bosmann M, Saeed M, Balasuriya UBR, Douam F, Crossland NA. Fatal neuroinvasion of SARS-CoV-2 in K18-hACE2 mice is partially dependent on hACE2 expression. bioRxiv. 2021 Jan 15. PMID: 33469581.
Read at: PubMed
View 54 more publications: View full profile at BUMC